Christine Blake
Family · Iowa City, IANPI 1184800021
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 67 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 12.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $552 and has fallen 89.8% since, to $56 in 2023.
Across 67 payments — averaging $15.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$132
- Novo Nordisk$88
- Lilly USA, LLC$85
- AbbVie$82
- AstraZeneca$70
- Biohaven Pharmaceuticals, Inc.$61
- plus $519 from 15 others
What the payments were for
- Food & beverage$1,038100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 7 | $132 |
| Novo Nordisk | 6 | $88 |
| Lilly USA, LLC | 6 | $85 |
| AbbVie | 5 | $82 |
| AstraZeneca | 5 | $70 |
| Biohaven Pharmaceuticals, Inc. | 4 | $61 |
| Amgen | 4 | $59 |
| Boehringer Ingelheim | 3 | $58 |
| Astellas Pharma US Inc | 3 | $57 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $53 |
| Amarin Pharma, Inc. | 3 | $50 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $37 |
| Merck | 3 | $37 |
| Abbott | 2 | $34 |
| GSK | 2 | $28 |
| Exact Sciences | 1 | $21 |
| Johnson & Johnson | 1 | $19 |
| Esperion Therapeutics, Inc. | 1 | $18 |
| Mylan Specialty L.p. | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
| Genentech USA, Inc. | 3 | $15 |
How this compares
$1,038 in reported general payments places this provider in the 80th percentile of 1,268 family providers in Iowa.
Other family in Iowa City
- Katie HalbmaierIowa City$9K
- Stefanie GaticaAnkeny$354K
- Aubrey MolgaardAmes$238K
- Joan KittenFort Dodge$85K
- Megan FergusonPella$82K
- Rodney ClarkDes Moines$63K
- Jennifer CondonFort Dodge$31K
- Karen HunkeAmes$20K
- Tonia AckermanWest Des Moines$17K
- Chi-Ying SageWaterloo$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.